A BRIEF REVIEW OF WILD HIMALAYAN PEAR PYRUS PASHIA
HTML Full TextA BRIEF REVIEW OF WILD HIMALAYAN PEAR PYRUS PASHIA
Shalini Sharma *, Komal Pathania and Bandna Sharma
School of Pharmacy and Emerging Sciences, Baddi University of Emerging Sciences & Technology, Baddi, Solan, Himachal Pradesh, India.
ABSTRACT: Within the Magnoliopsida class, Pyrus pashia is widely found throughout the Himalayan areas. P. pashia is a member of the Rosaceae family of medicinal plants. It's commonly called a wild pear. The plant has a range of nutritional and medicinal uses. In ethnomedicine, it is widely utilized as a hepatoprotective, inflammatory, antibacterial, antifungal, disinfectant, antioxidant, antimicrobial, and antidepressant to treat a wide range of illnesses. The genus P. pashia comprises approximately 38 species globally and contains approximately 160 phytochemical compounds, including primary and secondary metabolites such as alkaloids, glycosides, flavonoids, steroids, saponins, and tannins. Additionally, it contains useful polyphenolic therapeutic constituents like arbutin, flavan-3-ols, and chlorogenic acids. The phytochemistry, pharmacological activity, ethnomedicinal applications, and toxicological profile of P. pashia are all thoroughly updated in this review. This plant's scientific understanding as well as its potential for use in pharmaceutical research in the future, are critically examined.
Keywords: P. pashia, Phytochemicals, Medicinal plant, Pharmacological activity, Traditional uses
INTRODUCTION:
Taxonomy and Origin: P. pashia is a medium-sized deciduous tree in the Rosaceae family that falls under the scientific category Maloideae 1. P. pashia is primarily found in the Himalayas, which stretch from Pakistan to Vietnam and from the southern Chinese provinces to the northern regions of India 2, 3. The common term for P. pashia is "wild pear." It is specifically utilized in the treatment of disorders pertaining to the digestive system 1. The nutritional benefits of this plant's fruits are well known, and it is said that they are utilized to make herbal wines 4.
India's woods are a valuable source of a wide variety of medicinal plants that have both therapeutic and preventive uses for human health. The wild fruit species may become valuable resources for pharmaceuticals and financial gains to meet the needs of good development and nourishment. One example of a wild fruit is P. Pashia (Kainth), a member of the Rosaceae family that is widely distributed in the Himalayan region with excellent ethnic advantages and is widely used by local communities to treat vascular, pulmonary, and gastrointestinal issues 5, 1, 6, 7.
The fruit of the Kainth plant is rich in several phytochemicals that have beneficial effects on fitness and is also high in vitamins. The authors from the Kainth fruit 2 have reported 28 significant phenolic compounds. Since, Kainth is extremely perishable when fully ripe and cannot be moved, it is classified as an underutilized fruit. Fruits should be priced to reduce waste, increase local consumption, and enhance their value in the fight against malnutrition and other health issues 8. Wood is a superior gas source in the crucial Himalayan region, and leaf extract is utilized as a tonic against hair loss. The leaves have a sour taste and are fed to lambs and goats 9. The use of edible vegetation in the treatment of positive malignancies and cardiovascular illnesses is attributed to the presence of phenolic chemicals 10. Taxonomically, P. pashia is one of the 38 species that belongs to the genus Pyrus. All species of this genus are found in tropical and subtropical regions of Asia, Europe and South Asia. Most species produce bioactive constituents, especially phenols and polyphenols are used widely in ethnomedicine 2.
Different Pyrus Species and their site of Origin 11:
TABLE 1: SOME PRIMARY SPECIES OF PYRUS, GEOGRAPHICAL GROUP AND THEIR SITE OF ORIGIN
Geographic group | Species | Site of Origin |
Asian pear species | Pyrus armeniacifolia T. T. Yu | China |
Pyrus baccata var. himalaica Maxim. | China, Bhutan, India, Nepal | |
Pyrus betulifolia Bunge | China, Laos | |
Pyrus calleryana Decne. | China, Korea, Taiwan, Vietnam | |
Pyrus calleryana var. dimorphophylla (Makino) Koidz. | Japan | |
Pyrus calleryana var. fauriei (C. K. Schneid.) Rehder | Korea | |
Pyrus doumeri Bois | China, Taiwan, Laos, Vietnam | |
Pyrus foliolosa Wall. | Burma, Bhutan, India, Nepal, China | |
Pyrus harrowiana Balf. f.and W. W. Sm. | China, India, Nepal, Burma | |
Pyrus lanata D. Don | Afghanistan, India, Nepal, Pakistan | |
Pyrus sikkimensis Hook. f. | China, Bhutan, India | |
Pyrus vestita Wall. ex G. Don | China, Bhutan, India, Nepal, Myanmar | |
Europe and Southern Africa. | Pyrus aria (L.) Ehrh. var. cretica Lindl. | North Africa, Middle East, Central Europe Oriental and Southern and Turkmenistan |
Pyrus boissieriana Buhse | Azerbaijan, Turkmenistan, Iran | |
Pyrus caucasica Fed. | Eastern Europe and Central Greece | |
P. communis var. cordata (Desv.) H.f. | UK, Portugal, Spain, France | |
P. communis subsp. pyraster (L.) Ehrh. | Western Europe, Central Eastern, and Southern | |
Pyrus domestica (L.) Sm. | Algeria, Cyprus, Eastern Europe Central West and Meridional | |
Pyrus elaeagrifolia subsp. kotschyana | Turkey | |
Pyrus praemorsa Guss | South of Italy, France | |
Pyrus torminalis (L.) Ehrh. | North Africa, Middle East, South Caucasus, whole Europe | |
Americas | Pyrus americana DC | Greenland, USA, Canada |
Pyrus coronaria L. | Canada, USA | |
Pyrus arbutifolia (L.) L. f. | USA | |
P. coronaria var. ioensis Alph. Wood | USA | |
Pyrus diversifoliaBong. | USA, Canada | |
Pyrus fusca(Raf.) C. K. Schneid. | USA, Canada | |
Pyrus floribunda Lindl. | USA, Canada | |
Pyrus sanguinea Pursh | Canada, USA |
Botanical Description: The leaves are petiolate, with a length of 4.5 to 11 cm and a width of 2.5 to 4.2 cm. The petiole is crenate, reticulate crenate, ovate to lanceolate, and has an acute apex to acuminate. The leaves are stipulate. One-year-old shoots have alternating patterns of leaf emergence. A single leaf with a stipule emerges laterally on each node of two years old branches. The axil is never without a thorn. The thorn also produces 2 to 30 pubescent, alternating leaves. On the fruiting spurs of older wood, there are five to seven leaves 12. Fruit is a spherical berry. The size of the fruits varied from 1-2.5 cm in diameter. The surface of the fruit is dark greyish in colour bearing numerous densely distributed white and yellow spots. The fruit consists of fine wide radiating carpel chambers with one or two seeds attached in axile placentum 13.
Microscopic Characteristics 1: P. pashia has undergone microscopic investigations to determine its morphological characteristics, which are useful in differentiating it from other species. The microscopic features of the plant are as follows:
Leaf: Simple, alternating leaves with a petiole are present. The lamina has an obovate or elliptical form, with a little hairy lower surface and a smooth top surface. There is spongy parenchyma and palisade in the mesophyll.
Stem: The bark is smooth and covers the cylindrical stem. The cortex is made up of thin-walled cells arranged in many layers. There is a coating of sclerenchyma fibres around the dispersed vascular bundles.
Root: P. pashia has a taproot root system, and its cortex is made up of parenchyma cells with a few strewn sclerenchyma fibres. Concentric circles comprise the arrangement of the xylem and phloem.
Flower: P. pashia flowers are hermaphrodite and have five petals, five sepals, and many stamens. The style is long and narrow, and the ovary is superior.
Phytochemical Screening: For a qualitative phytochemical examination to determine whether P. pashia's crude ethanol extract included any secondary metabolites, such as alkaloids, saponins, anthraquinones, coumarins, sterols, terpenes, flavonoids, and phenols 14. Some of the major phytochemicals reported in P. pashia are listed below:
Flavonoids: Quercetin, kaempferol, luteolin, apigenin, and naringenin.
Phenolic Acids: Gallic acid, ellagic acid, chlorogenic acid, and caffeic acid.
Tannins: Condensed tannins, hydrolysable tannins, and proanthocyanidins.
Triterpenoids: Ursolic acid, oleanolic acid, betulinic acid, and maslinic acid.
Steroids: β-Sitosterol, stigmasterol and campesterol.
Chemical Constituents: In this plant secondary metabolites like Alkaloids, flavonoids, sterols, triterpenoids and phenolic compounds are present 15.
The methanolic extract of the fruits consists of d-Mannitol, 1,4-anhydro, Hexitol, Pentadecanoic Acid, 9,12-Octadecadienoic Acid (z, z), d-Mannitol, 1-o-(22-hydroxydocosyl), Octadecanoic acid, Squalene, Hexatriacontyl pentafluoro propionate, Stigmast-5-en-3-ol, (3. beta), Lup-20(29)-en-3-on, Lupeol, etc. 16.
FIG. 1: CHEMICAL CONSTITUENTS OF PYRUS PLANT
TABLE 2: PHYTOCHEMICALS REPORTED FROM PYRUS PLANT
Sr. no. | Name | Part Used | Phytoconstituents | References |
1. | Pyrus pashia | Stem | Hexacosanol, Hydroquinone, βsitosterol-β-D- glucoside, Luteolin glycoside. hen triacontanol, β-sitosterol, friedelin α-amyrin, Arborinol | 17. |
2 | Pyrus pashia | Seedling leaves | Apigenin7-glucoside, Luteolin 7- glucoside, Luteolin 4 ’glucoside, Chrysoenol 7-glucoside, Quercetin, Epicatechin, Catechin, Caffeoylcalleryanm, Caffeoyl arbutin, pCoumaroylarbutin, Arbutin, Acetyl arbutin | 18. |
3. | Pyrus pashia | Branches and Leaves | -3,5‑Dicaffeoylquinicacid methyl 3,5‑dicaffeoylquinate methyl 5‑O‑caffeoylquinate-4‑Hydroxy‑trans‑cinnamomicacid 4‑β‑D‑glucopyranosyloxybenzylester-4‑Hydroxy‑cis‑cinnamomic acid 4‑β‑D‑glucopyranosyloxy benzyl ester p‑Hydroxyphenyl6‑O‑trans‑p‑Coumaroyl‑β‑D‑glucopyranoside,p‑Hydroxyphenyl 6‑O‑cis‑p‑Coumaroyl‑β‑D‑glucopyranoside
-4‑Hydroxybenzoicacid - 4‑(methoxymethyl) phenyl‑1‑O‑β‑D‑glucopyranoside - 3,4‑Dihydroxyacetophenone - 3,4‑Dihytroxybenzaldehyde -Picein-Caffeic acid -trans‑p‑hydroxycinnamic acid - cedrusin- (+) ‑Isolarisiresinol - Arbutin, tannins, phloridzin, pectin, and amygdalin |
19-21 |
4. | Pyrus pashia | Flowers | - 4‑O‑Z‑coumaroylarbutin, 4‑hydroxy benzaldehyde (35)
-3,4‑Dihydroxy benzaldehyde, 4‑methoxy benzoic acid - 4‑Methoxymethyl‑phenol, 4‑ethoxymethyl‑phenol - E‑1‑(4'‑hydroxyphenyl) ‑buten‑1‑en‑3‑one - 3,4‑Dihydroxyl cinnamic acid; p‑hydroxy acetophenone - Cynanoneside A, 4,4'‑methylenediphenol - 3,3',4‑Trihydroxy‑diphenylmethane - Hydroquinone, arbutin, 6‑O‑acetylarbutin - 2‑O‑acetyl arbutin, 5‑O‑p‑cis‑coumaroyl quinic acid methyl ester- 5‑O‑p‑trans‑coumaroylquinic acid methyl ester - Gastrodin, 2‑methoxy‑4‑ (2‑ propenyl) phenyl β‑D‑glucopyranoside 3,5‑O‑caffeoylquinic acid, 3,5‑O‑caffeoylquinicacidmethylether - 8‑C‑p‑hydroxy benzyl apigenin- 3, 5 ,7, 4'‑Tetrahydroxy‑8‑ methoxyflavone‑3‑O‑β‑D‑glucopyranoside kaempferol 3‑rutinoside, apigenin - Apigenin 4'‑O‑β‑D‑glucopyranoside; and apigenin 7‑O‑β‑D‑glucopyranoside |
19. |
5. | Pyrus pashia | Fruits | Sitosterol, lupeol, Chrysin | 22. |
6. | Pyrus pashia | Bark | Steroids and tannins | 17. |
Pharmacological Activities:
Antimicrobial Activity: Using the disc diffusion method, the antimicrobial properties of petroleum ether, chloroform, ethyl acetate, acetone, methanol, ethanol, and water extracts of the medicinal plant Pyrus pashia were evaluated against ten bacterial strains and three fungal strains (different gram positive and gram negative). The ethanolic bark extracts of Pyrus pashia, comprising distinct fractions of bark, fruit, and leaf, demonstrated noteworthy efficacy (17±1 mm, 15±1 mm, and 14±1 mm) against Escherichia coli, Klebsiella pneumonia, and Shigella flexneri. The extractive values of the fruit of the medicinal plant were evaluated in fresh part weight. The ash value of the fruit was 1.10 ± 0.05%), moisture content was 60.36±0.25%, crude fat content was 1.62±0.20%, and crude fiber content was 5.26±0.05%. According to the preliminary phytochemical analysis test, there were 28.38±0.12% of carbohydrates along with glycosides, alkaloids, flavonoids, saponins, tannins, and unsaturated triterpenoids 23.
In-vivo Anti-inflammatory Activity: Methanolic leaf extract from P. pashia has anti-inflammatory properties in albino rats. Five sets of six rats each were used in this investigation. Group 2 was given 100 mg/kg of the standard reference medication Indomethacin, Group 3 received 50, 100, and 150 mg/kg of the methanol extract with 2 ml of 1% vanillin, and Group 5 received 1% saline as the control group. To cause paw edema, the rats were intradermally injected with 0.1 ml of a 1% solution of carrageenan into the plantar surface of their right hind limb. Plethysmographic measurements of the paw volume were made both prior to induction (0 H) and four hours later at one-hour intervals. Groups II, III, and IV's paw volumes were contrasted with the controls. Therefore, both methanolic extract dosages demonstrated an inhibitory effect on paw edema generated by carrageenan, demonstrating an anti-inflammatory activity against acute inflammation 24.
Hepatoprotective: Aqueous extract of P. pashia in CCl4 -induced hepatotoxicity in mice: hepatotoxicity was produced by CCl4 30% in olive oil (1 ml/kg i.p.), and mice were given oral doses of 250 and 500 mg/kg b.w.t. of the extract for a period of 14 days. Pre-treatment (once daily for 14 days prior to CCl4 intoxication) and post-treatment (2, 6, 24 and 48 hours following CCl4 intoxication) groups were both present. The observed protective effect may be explained by several phytochemicals promoting the healing of liver injury. Additionally, the histological analysis validates the hepatoprotection 25.
Gastrointestinal, Respiratory, Cardiovascular: In vitro tests were conducted on isolated rabbit jejunum, tracheal, and aorta preparations using the crude ethanol extract of P. pashia fruits. The study included male and female rabbits of the local strain, weighing between 1.0 and 1.8 kg, that were acquired from the local market and had an age limit of 6 to 7 months. These were kept in the animal home in a climate-controlled setting (23–25°C). Standard food and tap water were given to the animals on an as-needed basis. The animals had free access to water but were denied food for twenty-four hours before the studies began.
For use in in-vitro research, rabbits that had suffered a hit to the back of the head were slaughtered. Via several pathways, the aqueous ethanolic extract of P. pashia demonstrated vasoconstrictive, bronchodilator, and spasmolytic properties. Although α-adrenergic, muscarinic, serotonergic, and angiotensin II agonistic components may be present, blockage of Ca2+ channels are most likely the mechanism behind the bronchodilator and spasmolytic actions. The phytochemical components of P. pashia fruits namely, alkaloids, flavonoids, glycosides, and anthraquinones are responsible for the Ca2+ channel blocking action 10.
Anti-depressant Activity: Methanolic P. pashia leaf extract has antidepressant effects on albino rats. Rats were split into four groups for this study: the first was the control group, which received only distilled water orally; the second group was the standard group, which received imipramine hydrochloride (15 mg/kg) as the standard; the third group was the test group, which received T1 (100 mg/kg); and the fourth group was the test group, which received T2 (200 mg/kg) (p.o.). In both test groups, methanolic extracts of P. pashia leaves (100 and 200 mg/kg) were utilized as T1 and T2, respectively. The results showed that there was an antidepressant effect in FST and LMA that was dose dependent. Caffeic acid and genistein, two compounds found in P. pashia leaves, may contribute to the plant's antidepressant properties 26.
Anti-Convulsant Activity: Ethanolic extract of P. pashia (EPP) fruit has anti-convulsant properties in albino rats. To explore a potential treatment mechanism for EPP, the anticonvulsant effect of isolated chrysin was tested against experimental animal models.
The maximum electroshock (MES) and pentylenetetrazol (PTZ) models of experimental epilepsy were used to assess the anticonvulsant activity in terms of the duration of the onset of hind limb tonic extension and convulsion of standardized EPP, respectively. In addition, chrysin's antioxidant effectiveness against PTZ-induced convulsion in experimental mice and its anticonvulsant and electrophysiological characteristics were studied. The chrysin's neurotoxic profile was also evaluated using the rotarod apparatus and photo actometer for running and movement duration, respectively. In experimental rats, PTZ-induced convulsions and an acute form of MES were both significantly suppressed by EPP (100, 200, and 400 mg/kg). Additionally, rats given PTZ-induced convulsions showed notable anticonvulsant effect when given chrysin at doses of 2.5, 5, and 10 mg/kg. Furthermore, chrysin did not behave in a sedative-like manner in the rodent experiments. For the treatment of epilepsy, EPP may be a viable and different therapeutic strategy 27.
Medicinal Uses 10, 22, 24, 6, 27:
Plant part: Fruit:
- It is a common diet item among tribal groups; it helps with constipation, reduces thirst, manages dysentery,
- It is beneficial for eye issues, sedatives, and leishmaniasis. Beneficial for treating dyspepsia and dysmenorrhea, Irritability, sore throat, and digestive issues, anaemia and abdominal pain.
- Dried fruit decoction enhances stomach and spleen function. Cattle fodder was added to increase the amount of milk produced.
Plant Part: Leaves and Branches:
- Provideas grazing for sheep and goats
Leaf extract is used as a non-fermented beverage. - It improves cosmetic appearance.
- In Chinese traditional medicine, it cures diarrhoea and abdominal pain
- It is a tonic for hair loss.
Plant Part: Flower: In the Chinese region of Yunnan, it is used as a health food to lower blood cholesterol and to treat diarrhoea, emesis, and cough.
Plant Part: Bark:
- Has both tonic and astringent qualities. Helpful in treating typhoid fever
- Used to treat fever, peptic ulcers, and gastric ulcers.
CONCLUSION: P. pashia, or wild Himalayan pear, is a common name for this plant (Kainth). It is well known that the fruits of this plant have nutritional value and are utilized to make herbal wines. The fruit of the Kainth tree is rich in several phytochemicals that have beneficial effects on fitness and is also high in vitamins. In the vital Himalayan region, wood is a first-rate gas supplier, and leaf extract is employed as a tonic against hair loss. P.pashia has undergone microscopic examinations to determine its morphological characteristics, which are useful in differentiating it from other species. Bioactive components, particularly phenols and polyphenols, are produced by most species and are extensively employed in ethnomedicine. This review examines pharmacological actions that include antibacterial activity, in-vivo anti-inflammatory activity, hepatoprotective activity, and activity related to the digestive, respiratory, cardiovascular, antidepressant, and anti-convulsant systems. This review includes a comprehensive update on P. pashia phytochemistry, pharmacological activity, ethnomedicinal uses, and toxicological profile.
ACKNOWLEDGEMENT: The authors gratefully acknowledge the management of School of Pharmacy and Emerging Sciences, Baddi University of Emerging Sciences & Technology, Baddi, Solan-173205, Himachal Pradesh, India.
CONFLICTS OF INTEREST: The authors declare no conflicts of interest.
REFERENCES:
- Arya V, Gupta R and Gupta VK: Pharmacognostic and phytochemical investigations on Pyrus pashia Buch.-Ham. ex D. Don stem bark. Journal of Chemical and Pharmaceutical Research 2011; 3(3): 447–456.
- Prakash O, Baskaran R and Kudachikar VB: Characterization, quantification of free, esterified and bound phenolics in Kainth (Pyrus pashia Buch.-Ham. Ex D. Don) fruit pulp by UPLC-ESI-HRMS/MS and evaluation of their antioxidant activity. Food Chem 2019; 299: 125114.
- Wang Y and Cai L: Phenolic compounds and antioxidant activity of edible flowers of Pyrus pashia. Journal of Functional Foods 2015; 17: 371–379.
- Rana A and Singh HP: Bio-utilization of wild berries for preparation of high valued herbal wines. Indian Journal of Natural Products and Resources 2013; 4(2): 165–169.
- Kumar M, Sheikh MA and Bussmann RW: Ethnomedicinal and ecological status of plants in Garhwal Himalaya, India. Journal of Ethnobiology and Ethnomedicin 2011; 7: 32.
- Tsering J, Gogoi BJ and Tag H: Ethnobotany and phytochemical analysis of Pyrus pashia leaves. International Journal of Pharmaceutical Sciences and Research 2012; 3: 2721–2725.
- Sharma IP, Kanta C, Semwal SC and Goswami N: Wild fruits of Uttarakhand (India): Ethnobotanical and medicinal uses. International Journal of Complementary & Alternative Medicine 2017; 8(3): 00260.
- Weaver CM, Dwyer J, Fulgoni VL, KingJC, Leveille GA, MacDonald RS, Ordovas J and Schnakenberg D: Processed foods: Contributions to nutrition. The American Journal of Clinical Nutrition 2014; 99(6): 1525–1542.
- Thapa B, Walker DH and Sinclair FL: Indigenous knowledge of the feeding value of tree fodder. Animal Feed Science and Technology 1997; 67: 97–114.
- Janbaz KH, Ahsan MZ, Saqib F, Imran I, Zia-Ul-Haq M, Abid Rashid M and Moga M: Scientific basis for the use of Pyrus pashia Buch.-Ham. ex D. Don fruit in gastrointestinal, respiratory, and cardiovascular ailments. PLoS ONE 2015; 10(3):
- Silva GJ, Barbieri RL and Souza TM: Origin, domestication, and dispersing of pear (Pyrus species). Advances in Agriculture 2014; 1-8.
- Siddiqui SZ, Ali S, Rubab K, Abbasi MA, Ajaib M and Rasool ZG: Pyrus pashia: A persuasive source of natural antioxidants. Pakistan Journal of Pharmaceutical Sciences 2015; 28(5).
- Hemalatha S, Sharma P and Prasad SK: Quality control standardization of wild Himalayan pear: Pyrus pashia. Pharmacognosy Journal 2016; 8(4): 352-360.
- Tona L, Kambu K, Ngimbi N, Cimanga K and Vlietinck AJ: Antiamoebic and phytochemical screening of some Congolese medicinal plants. Journal of Ethnopharmacology 1998; 61(1): 57-65.
- Zamani A, Atar F and Jouharchi MR: Pyrus pashia (Rosaceae), a new record for the flora of Iran. Journal of Biological Sciences 2009; 9(1): 72-75.
- Mian Z, Cai L and Zhongtao D: Chemical constituents from leaves and branches of Pyrus pashia. Chinese Journal of Organic Chemistry 2013; 33: 1284-1290.
- Gupta VK, Arya V and Gupta R: Pharmacognostic and phytochemical investigations on Pyrus pashia Buch. Ham. ex D. Don stem bark. Journal of Chemical and Pharmaceutical Research 2011; 3(5): 447-456.
- Challice JS and Westwood MN: Phenolic compounds of the genus Pyrus. Phytochemistry1972; 11(1): 37-44.
- HeJ, Yin T, Chen Y, Cai L, Tai Z, Li Z, Liu C, Wang Y and Ding Z: Phenolic compounds and antioxidant activities of edible flowers of Pyrus pashia. Journal of Functional Foods 2015; 17: 371-379.
- Li ZJ, Zheng X, Wan CP, Cai L, Li Y, Huang L and Ding ZT: A new phenolic compound with antioxidant activity from the branches and leaves of Pyrus pashia. Natural Product Research 2016; 30(10): 1136-1143.
- Lia ZJ, Wan CP, Cai L, Li SQ, Zheng X, Qi Y, Dong JW, Yin TP, Zhou ZX, Tan NH and Ding ZT: Terpenoids with cytotoxic activity from the branches and leaves of Pyrus pashia. Phytochemistry Letters 2015; 13: 246–251.
- Khandelwal R, Paliwal S, Chauhan R and Siddiqui A: Phytochemical screening of hexane soluble fraction of Pyrus pashia fruits. Oriental Journal of Chemistry 2008; 24(2): 773–774.
- Saklani S and Chandra S: In-vitro antimicrobial activity and nutritional profile of medicinal plant of Garhwal, Himalaya. International Journal of Pharmaceutical Sciences and Research 2012; 3(2): 268–272.
- Chandra S, Saklani S and Kumar S: In-vivo anti-inflammatory activity of Pyrus pashia fruit. World Journal of Pharmaceutical Sciences 2016; 4(2): 273–276.
- Athokpam R, Bawari M and Choudhury MD: Hepatoprotective activity of aqueous extract of Pyrus pashia Buch.-Ham. Ex D. Don against CCl4 induced liver damage. International Journal of Pharmaceutical Sciences and Research 2017; 8(10): 4195–4200.
- Sharma P, Kumari A, Gulati A, Krishnamurthy S and Hemalatha S: Chrysin isolated from Pyrus pashia fruit ameliorates convulsions in experimental animals. Nutritional Neuroscience 2019; 22(8): 569–577.
- Cai L, Zhao M, Liu S, Yin T, Zhou H, Dong J, Yang Y and Ding Z: Pashinintide A, the first plant cyclopeptide from Rosaceae, included a sucrose, suggests a new natural receptor for saccharide. Tetrahedron Letters 2014; 55(33): 6231–6235.
How to cite this article:
Sharma S, Pathania K and Sharma B: A brief review of wild Himalayan pear Pyrus pashia. Int J Pharm Sci & Res 2025; 16(3): 584-90. doi: 10.13040/IJPSR.0975-8232.16(3).584-90.
All © 2025 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
1
584-590
582 KB
232
English
IJPSR
Shalini Sharma *, Komal Pathania and Bandna Sharma
School of Pharmacy and Emerging Sciences, Baddi University of Emerging Sciences & Technology, Baddi, Solan, Himachal Pradesh, India.
prakriti88b@gmail.com
03 September 2024
06 November 2024
12 November 2024
10.13040/IJPSR.0975-8232.16(3).584-90
01 March 2025